ArticleGastroenterology research and practice2012
Atypical celiac disease: from recognizing to managing.
Article in Gastroenterology research and practice, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 2 syntheses or guidelines pooled it, 65 citations in OpenAlex.
- Mood Disorders and Gluten: It's Not All in Your Mind! A Systematic Review with Meta-Analysis.Nutrients · 2018Pooled it
- Prevalence of celiac disease in latin america: a systematic review and meta-regression.PloS one · 2015Pooled it
- Newly Diagnosed Celiac Disease in a Patient With a Body Mass Index of 50.8 kg/mJGH open : an open access journal of gastroenterology and hepatology · 2025Article
- Hypoalbuminemia as an Unusual Presentation of Undiagnosed Atypical Celiac Disease in an 84-Year-Old Woman.Annals of geriatric medicine and research · 2025Article
- Automatically pre-screening patients for the rare disease aromatic l-amino acid decarboxylase deficiency using knowledge engineering, natural language processing, and machine learning on a large EHR population.Journal of the American Medical Informatics Association : JAMIA · 2024Article
- Celiac disease - a pluripathological model in pediatric practice.Frontiers in immunology · 2024Review
- Celiac Disease on the Bed-Side: Embedding Case Finding and Screening in Hospitalized Children.Nutrients · 2023Article
- Article
- Prevalence of celiac disease in Moroccan children with type 1 diabetes mellitus: A 16-year cross-sectional study.Qatar medical journal · 2023Article
- Reduced frequency of circulating regulatory T cells and their related immunosuppressive mediators in treated celiac patients.Molecular biology reports · 2022Article
- New-onset celiac disease in children during COVID-19 pandemic.Acta paediatrica (Oslo, Norway : 1992) · 2022Article
- TagSNP approach for HLA risk allele genotyping of Saudi celiac disease patients: effectiveness and pitfalls.Bioscience reports · 2021Article
- Onset of menarche is not delayed in Slovenian patients with celiac disease.The Journal of international medical research · 2019Article
- Pediatric Celiac Disease in Central and East Asia: Current Knowledge and Prevalence.Medicina (Kaunas, Lithuania) · 2019Review
- Implications of Celiac Disease Among Patients Undergoing Gastric Bypass.Obesity surgery · 2018Article
- Screening of celiac disease in Down syndrome - Old and new dilemmas.World journal of clinical cases · 2017Review
- Iron for Africa-Report of an Expert Workshop.Nutrients · 2017Article
- Understanding Celiac Disease From Genetics to the Future Diagnostic Strategies.Clinical medicine insights. Gastroenterology · 2017Review
- Outcomes of Seropositive Patients With Marsh 1 Histology in Clinical Practice.Journal of clinical gastroenterology · 2016Article
- Elevated Total Iron-Binding Capacity Is Associated with an Increased Risk of Celiac Disease.Digestive diseases and sciences · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The nonclassic clinical presentation of celiac disease (CD) becomes increasingly common in physician's daily practice, which requires an awareness of its many clinical faces with atypical, silent, and latent forms. Besides the common genetic background (HLA DQ2/DQ8) of the disease, other non-HLA genes are now notably reported with a probable association to atypical forms. The availability of high-sensitive and specific serologic tests such as antitissue transglutuminase, antiendomysium, and more recent antideamidated, gliadin peptide antibodies permits to efficiently uncover a large portion of the submerged CD iceberg, including individuals having conditions associated with a high risk of developing CD (type 1 diabetes, autoimmune diseases, Down syndrome, family history of CD, etc.), biologic abnormalities (iron deficiency anemia, abnormal transaminase levels, etc.), and extraintestinal symptoms (short stature, neuropsychiatric disorders, alopecia, dental enamel hypoplasia, recurrent aphtous stomatitis, etc.). Despite the therapeutic alternatives currently in developing, the strict adherence to a GFD remains the only effective and safe therapy for CD.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.